Ligand validation:8YD3

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8YD3_GOL_D_202	43%	50%	0.169	0.893	0.82	1.12	-	-	1	0	100%	1
8YD3_GOL_F_202	31%	48%	0.195	0.864	0.78	1.2	-	-	4	0	100%	1
8YD3_GOL_B_203	31%	44%	0.206	0.875	1.01	1.17	-	1	7	0	100%	1
8YD3_GOL_C_202	23%	45%	0.235	0.86	0.91	1.19	-	1	4	0	100%	1
8YD3_GOL_A_202	23%	52%	0.26	0.884	0.65	1.18	-	1	1	0	100%	1
6A9O_GOL_B_202	49%	58%	0.171	0.919	0.77	0.84	-	-	2	0	100%	1
6SPA_GOL_J_202	35%	83%	0.21	0.897	0.1	0.67	-	-	5	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.